NCT05245136View on ClinicalTrials.gov

Augsburg Longitudinal Plasma Study for the Evaluation of Liquid Biopsy as Diagnostic Tool.

RecruitingOBSERVATIONAL

Enrollment

3,000

Participants

Timeline

Start Date

March 29, 2021

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions

Characteristics DiseaseMetastatic CancerSolid Tumor

Trial Locations (1)

86156

RECRUITING

University Hospital Augsburg, Augsburg

All Listed Sponsors

lead

University Hospital Augsburg

OTHER